drugset / Trial / NCT01198795
Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the long-term safety and tolerability of escitalopram (Lexapro) in children 7 to 11 years of age with major depressive disorder (MDD).
Timeline
- Start
- 2010-09
- Primary completion
- 2013-01
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 10 mg | Oral |
| Subject | Escitalopram | Small molecule | 20 mg | Oral |